Response to trastuzumab deruxtecan and delayed immune-related events in a patient with metastatic HER2-positive NSCLC: a case report and literature review
Lu Wang, Shidi Wen, Wenjia Zhu, Zhiyang Zhang, Yuejuan Cheng · 2025
Read Response to trastuzumab deruxtecan and delayed immune-related events in a patient with metastatic HER2-positive NSCLC: a case report and literature review by Lu Wang, Shidi Wen, Wenjia Zhu, Zhiyang Zhang, Yuejuan Cheng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11782023.txt.
Description
Wang and coauthors report a lung cancer case with late immune side effects. The patient had spread lung cancer with a HER2 gene change. First immune care failed to hold the cancer back. A drug that links an antibody to a toxin was tried next.
The patient responded well to that linked drug. Five months after immune care stopped, adrenal failure arose. That late effect links to the prior immune care, not the new drug. The team reviews how linked drugs kill cancer cells. They also weigh how such drugs may shift the tumor milieu. The case guides care for like patients.
Catalog record
| CREATOR | Lu Wang, Shidi Wen, Wenjia Zhu, Zhiyang Zhang, Yuejuan Cheng |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |